---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-047191"
form_type: "8-K"
ticker: "IMRX"
cik: "0001790340"
company_name: "Immuneering Corp"
filed_at: "2023-04-19T23:59:59+00:00"
generated_at: "2026-06-16T23:47:55.404817+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Immuneering announces $27.8M public offering of 2.73M shares at $11.00/share

## Summary
- Entered underwriting agreement with Jefferies, Cowen and Guggenheim for 2,727,273 shares at $11.00/share.
- Expected net proceeds of approximately $27.8M after underwriting discounts and offering expenses.
- Proceeds to fund preclinical and clinical development of product candidates and for working capital.
- Closing expected on or about April 20, 2023, subject to customary closing conditions.

## SEC filing metadata
- accession: 0001104659-23-047191
- form_type: 8-K
- ticker: IMRX
- cik: 0001790340
- company_name: Immuneering Corp
- filed_at: 2023-04-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1790340/000110465923047191/0001104659-23-047191-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1790340/000110465923047191/tm2313152d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-047191
- JSON: https://secwatch.observer/filing/0001104659-23-047191.json
- Plain text: https://secwatch.observer/filing/0001104659-23-047191.txt

## Key facts
- Material Agreements
  Immuneering Corp entered into Underwriting Agreement with Jefferies LLC, Cowen and Company, LLC and Guggenheim Securities, LLC, as representatives of the several underwriters valued at approximately $27.8 million (effective 2023-04-18).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Jefferies LLC, Cowen and Company, LLC and Guggenheim Securities, LLC, as representatives of the several underwriters
  - Value: approximately $27.8 million
  - Effective: 2023-04-18
  source text: On April 18, 2023, Immuneering Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, Cowen and Company, LLC and Guggenheim Securities, LLC, as representatives of the several underwriters listed on Schedule I attached thereto (the “Underwriters”), in connection with the public offering, issuance and sale by the Company of 2,727,273 shares of the Company’s Class A common stock, $0.001 par value per share (the “Common Stock”), at a public offering price of $11.00 per share, less underwriting discounts and commissions, pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-266738) and a related prospectus supplement filed with the Securities and Exchange Commission (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1790340/000110465923047191/0001104659-23-047191-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.